Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors Undergoing Hormone Therapy (GREENS)
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 55 Years to 85 Years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 10 weeks
- Procedures mentioned: Blood draws
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "OUTLINE: Patients participate in the golf training program composed of group sessions over 1-2 hours with a Professional Golfers' Association of America (PGA) professional two times per week for ten weeks."
- "Patients also wear an activity tracker and undergo blood sample collection on the study."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * First time, primary diagnosis of prostate cancer (PCa) * Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months * Older adult male: 55-85 years old * The ability to stand independently without external support * No or minimal golf experience (played \< 5 times in the past 10 years) * English speaking Exclusion Criteria: * Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases * Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry) * Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) \> 160 or diastolic blood pressure (DBP) \> 90, high resting pulse heart rate (HR) \> 90), symptomatic orthostatic hypotension * Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD\] * History of injury or orthopedic operation within the last 6 months * Movement disorders (e.g., Parkinson's disease (PD) or other neurological disorders), hemiparesis or paraparesis * Severe vision or hearing problems
Study sites (2)
CA
- Los Angeles General Medical Center · Los Angeles, CA 90033George Salem, PhD · Study contact · 323-442-3113 · gsalem@usc.eduGeorge Salem, PhD · Principal investigatorMore trials in Los Angeles
- USC / Norris Comprehensive Cancer Center · Los Angeles, CA 90033George Salem, PhD · Study contact · 323-442-3113 · gsalem@usc.eduGeorge Salem, PhD · Principal investigatorMore trials in Los Angeles